HudsonAlpha to use Sequencing to Uncover Genes Responsible for Adverse Drug Response in Parkinson's

"If we could identify a gene, or small set of genes, which determine whether you are at risk for side effects of levodopa, it would really change our [treatment] approach," David Standaert, a neurologist at the University of Alabama, told Clinical Sequencing News.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.